M14.65
Charcôt's joint, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Charcot's joint, also known as neurogenic joint destruction, affects the hip when nerves that supply the joint are damaged, leading to progressive degeneration. It is characterized by joint swelling, instability, and deformity, often with little pain due to nerve damage. This condition typically develops over time and requires careful management to prevent severe damage and restore function.
Causes & Symptoms
Clinical Causes: Nerve damage from conditions like diabetes mellitus leading to peripheral neuropathy Multiple sclerosis Syphilis or other infections causing nerve impairment Trauma resulting in nerve injury Other neurological disorders affecting sensation and muscle control
Key Symptoms: Gradual swelling and enlargement of the hip joint Decreased or absent pain in the affected area despite significant damage Joint instability and abnormal movement Deformities such as limb shortening or misalignment Reduced range of motion or stiffness Possible skin changes over the joint, including redness or ulceration in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, and imaging studies. Healthcare providers may use:
Treatment Protocols: Management focuses on stabilizing the joint and preventing further damage. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M14.65 a billable ICD-10 code?
Yes, M14.65 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M14.65?
Clinical documentation must specify the nature of Charcôt's joint, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference